Tag: Pharmaceutical Research and Manufacturers of America

F.D.A. to Issue First Approval for Mass Drug Imports to States from Canada

The agency plans to authorize Florida to purchase medicines directly from wholesalers in Canada, where prices are far cheaper. Pharmaceutical companies oppose the plan.

Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations

The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.

FDA’s Drug Industry Fees Fuel Concerns Over Influence

The pharmaceutical industry finances about 75 percent of the agency’s drug division, through a controversial program that Congress must reauthorize by the end of this month.

Medicare Recipients Could Find Drug Cost Relief in Health Bill

Starting in 2025, Medicare recipients with prescription drug coverage will not have to pay more than $2,000 annually for medications, a significant savings for some.

Democrats Offer Plan to Cut Drug Costs, Seeking Climate and Tax Deal

The drug-pricing plan was negotiated with Senator Joe Manchin III of West Virginia, but Democrats remain short of agreement on what else would be included in any domestic policy package.